School of Dentistry and Medical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.
Genentech, 1 DNA Way, South San Francisco, CA, 94080, USA.
Sci Rep. 2022 Aug 17;12(1):14010. doi: 10.1038/s41598-022-17384-9.
Gonorrhoea infection rates and the risk of infection from opportunistic pathogens including P. aeruginosa have both risen globally, in part due to increasing broad-spectrum antibiotic resistance. Development of new antimicrobial drugs is necessary and urgent to counter infections from drug resistant bacteria. Aspartate-semialdehyde dehydrogenase (ASADH) is a key enzyme in the aspartate biosynthetic pathway, which is critical for amino acid and metabolite biosynthesis in most microorganisms including important human pathogens. Here we present the first structures of two ASADH proteins from N. gonorrhoeae and P. aeruginosa solved by X-ray crystallography. These high-resolution structures present an ideal platform for in silico drug design, offering potential targets for antimicrobial drug development as emerging multidrug resistant strains of bacteria become more prevalent.
淋病感染率和包括铜绿假单胞菌在内的机会性病原体的感染风险在全球范围内都有所上升,部分原因是广谱抗生素耐药性的增加。开发新的抗菌药物对于对抗耐药菌感染是必要和紧迫的。天冬氨酸半醛脱氢酶(ASADH)是天冬氨酸生物合成途径中的关键酶,对于包括重要人类病原体在内的大多数微生物的氨基酸和代谢物生物合成至关重要。在这里,我们通过 X 射线晶体学解决了淋病奈瑟菌和铜绿假单胞菌的两种 ASADH 蛋白的首个结构。这些高分辨率结构为计算机药物设计提供了一个理想的平台,为抗菌药物的开发提供了潜在的靶点,因为新兴的多药耐药菌越来越普遍。